Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02391324 · ClinicalTrials.gov registry record · NA

Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy

A NA study of Cerebral Palsy, sponsored by University of Alberta.

Recruiting
Registry status
NA
Development phase
160
Enrollment target
3
Study locations

NCT02391324: Recruiting NA study of Cerebral Palsy, sponsored by University of Alberta.

NCT02391324 is a NA study of Cerebral Palsy that is actively recruiting participants, run by University of Alberta. The registered enrollment target is 160 participants, below the 228-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (30% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02391324, a NA study of Cerebral Palsy, is actively recruiting participants, sponsored by University of Alberta.

RECRUITING
Registry status
NA
Development phase
160 participants
Enrollment target
3
Study locations

Study Summary

Robot assisted gait training is seen as a promising intervention for improving the walking abilities of children with cerebral palsy, but research to support its effectiveness compared to best practice physical therapy is lacking. This research consists of a randomized controlled trial (RCT) and a qualitative descriptive study that is linked with the RCT. The goal of the RCT is to compare: 1) a walking training program with the Lokomat® robotic device (LOK), 2) a functional physical therapy program (fPT) that includes activities to enhance balance/co-ordination/endurance and advanced motor skills conducted over 'real ground', 3) a combined Lokomat® + functional physical therapy (LOK+fPT) program, and 4) a regular maintenance therapy condition (CONT) for ambulatory children and youth with CP (aged 5- 18 years). The three intervention programs will consist of sixteen 50-minute sessions given twice weekly over 8 to 10 weeks. The primary objective of the RCT is to compare the four groups with respect to walking-related motor skills as measured by the Gross Motor Function Measure. The secondary objectives are to compare each intervention's impact on walking abilities, individualized goals, fitness, balance, physical activity levels, child's belief in ability to do physical activity, participation and quality of life. The investigators will also evaluate the extent of carryover or progress 3 months after the intervention. The qualitative part of the study will consist of interviews of children and parents after they have finished the study intervention. The information from the interviews will assist us with interpretation of the outcome results (areas of impact and amount of change) from the RCT. In particular, the interviews will 1) provide insight into their experiences with the trial interventions, 2) identify the mobility-related outcomes that are important to families and the factors that influence their preferences, and 3) explain the family values, experiences and

Primary Outcome

A standardized measure of gross motor function for children with cerebral palsy

Conditions Studied

Interventions

  • PROCEDURE Lokomat (LOK)
  • PROCEDURE Gait focused physical therapy (fPT)
  • PROCEDURE LOK + fPT

Study Locations (3)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Alberta

  • University of Alberta - Edmonton

Ontario

  • Holland Bloorview Kids Rehabilitation Hospital - Toronto

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2016-01
Est. Completion 2025-03-31
Phase NA
University of Alberta

19 total trials

What NCT02391324 shows while recruiting

NCT02391324 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 228-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (30% lower).

The record links to 1 condition, with Cerebral Palsy appearing as the primary indexed condition, and to 3 interventions - of which Lokomat (LOK) is the first listed.

NCT02391324 reports a single indexed study location in Illinois, Alberta, Ontario.

Frequently Asked Questions

What is clinical trial NCT02391324 about?

NCT02391324 is a clinical study titled "Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy". Robot assisted gait training is seen as a promising intervention for improving the walking abilities of children with cerebral palsy, but research to support its effectiveness compared to best practice physical therapy is lacking. This research consists of a randomized controlled trial (RCT) and a q...

What is the current status of trial NCT02391324?

This trial is currently recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2016-01. Estimated completion is 2025-03-31.

What conditions does trial NCT02391324 study?

This clinical trial studies the following conditions: Cerebral Palsy.

What interventions are being tested in trial NCT02391324?

The interventions under investigation include: Lokomat (LOK) (PROCEDURE), Gait focused physical therapy (fPT) (PROCEDURE), LOK + fPT (PROCEDURE).

Who is sponsoring clinical trial NCT02391324?

This trial is sponsored by University of Alberta, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02391324 being conducted?

This trial has 3 study locations across Illinois, Alberta, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02391324's enrollment target sits among peer trials

160 13th of 91 higher than 78 of 91 other Cerebral Palsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00501826 · 160 participants · Phase 2

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

  • NCT00932139 · 160 participants · NA

    Effect of Electro-Acupuncture on Blood Pressure

  • NCT00992901 · 160 participants · Early Phase 1

    Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery

  • NCT01515527 · 160 participants · Phase 2

    Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02391324, the US trial registry maintained by the National Library of Medicine. NCT02391324 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.